Our study indicates that, in CRSwNP patients, IL-17 family cytokines (IL-17A, IL-22, and IL-26) can significantly disrupt epithelial barrier function in association with a disruption of tight junction integrity and without causing cellular toxicity. The gene discussed is IL17A; the disease is chronic rhinosinusitis with nasal polyps.